Medicine and Dentistry
Nasopharynx Cancer
100%
Cytotechnology
75%
Neoplasm
69%
Cyclin D1
66%
Papillary Thyroid Cancer
66%
Nasopharynx Carcinoma
66%
Gelatinase B
66%
Malignant Neoplasm
64%
Histopathology
58%
Sensitivity and Specificity
56%
Immunohistochemistry
52%
Wart Virus
50%
Cross Sectional Study
47%
Lymph Node Metastasis
46%
Fine-Needle Aspiration
45%
Diagnostic Test
43%
Prevalence
40%
Retrospective Cohort Study
40%
Cancer
38%
Diagnostic Accuracy
37%
Cervical Cancer
35%
Salivary Gland Disease
33%
Nasoendoscopy
33%
Narrow Band Imaging
33%
Survivin
33%
Patient Referral
33%
Metalloprotease Inhibitor
33%
Vasomotor Rhinitis
33%
Turbinate
33%
Mycoplasma hominis
33%
Royal Jelly
33%
Chemokine Receptor
33%
Chlamydia Trachomatis
33%
Vasculotropin
33%
Nasopharyngeal Angiofibroma
33%
Gelatinase A
33%
Interstitial Collagenase
33%
Histamine Antagonist
33%
Recurrent Disease
33%
Fibronectin
33%
Treatment Response
33%
Infection
33%
Epidermal Growth Factor Receptor
33%
Non Small Cell Lung Cancer
33%
Salivary Gland
33%
Cancer Registry
33%
Randomized Clinical Trial
33%
Mesothelioma
33%
Gene Expression
33%
Larynx Squamous Cell Carcinoma
33%
Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Indonesia
87%
Cancer Patients
74%
Cyclin D1 (CCND1)
66%
Jakarta
56%
Diagnostic Test
43%
Common Cancers
42%
Retrospective Cohort Study
41%
High-risk Human Papillomavirus (HR-HPV)
40%
Advanced Stage
38%
Diagnostic Accuracy
37%
Cytological Samples
37%
Surgical Variables
33%
Acalypha
33%
Neuronal Damage
33%
Hippocampal Damage
33%
Narrow Band Imaging
33%
Advanced Nasopharyngeal Carcinoma
33%
BRAF V600E
33%
Salivary Gland Lesions
33%
Cytomorphology
33%
Acute Non-lymphocytic Leukemia
33%
Persistent Allergic Rhinitis
33%
Radiofrequency Turbinate Reduction
33%
Intranasal Antihistamines
33%
Intranasal Steroids
33%
Mesothelioma Cells
33%
Non-small Cell
33%
Fibronectin 1
33%
Fine-needle Aspiration
33%
Intervention Group
33%
Survivin Expression
33%
Nasoendoscopy
33%
Mycoplasma Hominis
33%
Mutational Status
33%
Chlamydia Trachomatis
33%
Papillary Thyroid Carcinoma
33%
RAS-like
33%
Matrix metalloproteinase-2 (MMP-2)
33%
Uterine Cervical
33%
RAS mutational Status
33%
KRAS mutation
33%
Referral Hospital
33%
Indonesian
33%
Cervical Malignancy
33%
C(X)
33%
Juvenile Nasopharyngeal Angiofibroma
33%
Vascular Endothelial Growth Factor Expression
33%
Expression Level
33%
Carcinoma
33%
Pharmacology, Toxicology and Pharmaceutical Science
Nasopharynx Cancer
100%
Cyclin D1
66%
Thyroid Papillary Carcinoma
66%
Malignant Neoplasm
64%
Neoplasm
54%
Infection
52%
Human Papillomavirus
50%
Prevalence
44%
Cross-Sectional Study
41%
Cohort Study
37%
Fibronectin
33%
5 Amino 4 Imidazolecarboxamide
33%
Gelatinase A
33%
Tissue Inhibitor of Metalloproteinase
33%
Perennial Rhinitis
33%
Acalypha
33%
Vasomotor Rhinitis
33%
Interstitial Collagenase
33%
Mycoplasma hominis
33%
Chlamydia Trachomatis
33%
Royal Jelly
33%
Injury
33%
Gelatinase B
33%
Antihistaminic Agent
33%
Hypoxia
33%
Cancer Registry
33%
Nasopharynx Carcinoma
33%
Chemokine Receptor
33%
Randomized Clinical Trial
33%
Systemic Lupus Erythematosus
33%
Invasive Aspergillosis
33%
Symptom
30%
Citicoline
25%
Persistent Infection
25%
Uterine Cervix Cancer
24%
Disease
21%
Bacterial Infection
16%
Scar Formation
16%
Surgical Wound
16%
Autoimmune Disease
14%
Aspergillosis
14%
Lymph Vessel Metastasis
13%
Lymph Node Metastasis
13%
Cancer Staging
12%
Chemotherapy
11%
Enzyme-Linked Immunosorbent Assay
11%
Pharmacotherapy
11%
Retrospective Study
11%
Epileptic Absence
11%
Nerve Cell Lesion
8%
